51 results
Page 2 of 3
PRE 14A
1mzzkpqu
13 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.1
kw2 36pjr5r
10 Nov 22
Nuvalent Reviews Corporate and Pipeline Achievements and Reports Third Quarter 2022 Financial Results
6:37am
8-K
EX-99.1
hslvix 5mc
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
424B5
opxchw5ympl3k2a
1 Nov 22
Prospectus supplement for primary offering
5:17pm
424B5
2be1m8cwfjndbte4fg
31 Oct 22
Prospectus supplement for primary offering
7:21am
8-K
g71vqes4dj
28 Oct 22
Other Events
6:05am
8-K
EX-99.1
mny46kk8ysajy7sy0zan
28 Oct 22
Other Events
6:05am
424B5
05w8myp
17 Aug 22
Prospectus supplement for primary offering
4:23pm
S-3
nkqt2d jo
10 Aug 22
Shelf registration
8:35am
8-K
EX-99.1
i0iiszdap gyrhafi7v
10 Aug 22
Nuvalent Highlights Execution Across Pipeline of Novel Kinase Inhibitors and Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
0xn xio2u
12 May 22
Nuvalent Highlights Pipeline and Business Progress and Reports First Quarter 2022 Financial Results
6:45am
10-K
hbcogl7 i6pka1lo
29 Mar 22
Annual report
7:21am
8-K
EX-99.1
dj8jh tpixkyn3iiaklz
29 Mar 22
Nuvalent Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
6:58am
8-K
7week 5jy4d
7 Jan 22
Results of Operations and Financial Condition
6:40am
8-K
EX-99.1
xr68tn
10 Nov 21
Nuvalent Reports Pipeline Progress and Third Quarter 2021 Financial Results
6:44am
10-Q
6zwcplpcmhkq7z5i ng
8 Sep 21
Quarterly report
8:31am